دورية أكاديمية

Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.

التفاصيل البيبلوغرافية
العنوان: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.
المؤلفون: Edwards, Kristina R, Schmidt, Karina, Homad, Leah J, Kher, Gargi M, Xu, Guoyue, Rodrigues, Kristen A, Ben-Akiva, Elana, Abbott, Joe, Prlic, Martin, Newell, Evan W, De Rosa, Stephen C, Irvine, Darrell J, Pancera, Marie, McGuire, Andrew T
المصدر: Cell Rep Med ; ISSN:2666-3791
بيانات النشر: Elsevier Science
سنة النشر: 2024
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: Epstein-Barr virus, adjuvants, challenge studies, nanoparticles, neutralizing antibodies, rhesus lymphocryptovirus, vaccines
الوصف: Epstein-Barr virus (EBV) is associated with infectious mononucleosis, cancer, and multiple sclerosis. A vaccine that prevents infection and/or EBV-associated morbidity is an unmet need. The viral gH/gL glycoprotein complex is essential for infectivity, making it an attractive vaccine target. Here, we evaluate the immunogenicity of a gH/gL nanoparticle vaccine adjuvanted with the Sigma Adjuvant System (SAS) or a saponin/monophosphoryl lipid A nanoparticle (SMNP) in rhesus macaques. Formulation with SMNP elicits higher titers of neutralizing antibodies and more vaccine-specific CD4+ T cells. All but one animal in the SMNP group were infected after oral challenge with the EBV ortholog rhesus lymphocryptovirus (rhLCV). Their immune plasma had a 10- to 100-fold lower reactivity against rhLCV gH/gL compared to EBV gH/gL. Anti-EBV neutralizing monoclonal antibodies showed reduced binding to rhLCV gH/gL, demonstrating that EBV gH/gL neutralizing epitopes are poorly conserved on rhLCV gH/gL. Prevention of rhLCV infection despite antigenic disparity supports clinical development of gH/gL nanoparticle vaccines against EBV.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.1016/j.xcrm.2024.101587Test; https://pubmed.ncbi.nlm.nih.gov/38781964Test
DOI: 10.1016/j.xcrm.2024.101587
الإتاحة: https://doi.org/10.1016/j.xcrm.2024.101587Test
https://pubmed.ncbi.nlm.nih.gov/38781964Test
حقوق: Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
رقم الانضمام: edsbas.375E608C
قاعدة البيانات: BASE